SCHEMBL21802124

SCHEMBL21802124

CCOC(=O)CN(Cc1ccccc1)C[C@H]1COC(C)(C)N1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.38
PPID Q08752 1/20 0.37
MAPT P10636 4/20 0.37
PIN1 Q13526 1/20 0.37
ALDH1A1 P00352 4/20 0.36
F2 P00734 2/20 0.36
F10 P00742 2/20 0.36
ITGB3 P05106 2/20 0.36
ITGA2B P08514 2/20 0.36
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7499187 0.89 SPHK1 (0.37) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL6719410 0.89 SPHK1 (0.37) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL7499191 0.89 SPHK1 (0.37) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL3184733 0.76 ALDH1A1 (0.54) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL3612312 0.76 SPHK1 (0.40) TP53MAPTL3MBTL1
SCHEMBL3612306 0.76 SPHK1 (0.40) TP53MAPTL3MBTL1
SCHEMBL254781 0.74 ALDH1A1 (0.53) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL11180129 0.73 ALDH1A1 (0.49) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL5653101 0.73 TP53 (0.44) TP53PPIDMAPTPIN1ALDH1A1
SCHEMBL5653096 0.73 TP53 (0.44) TP53PPIDMAPTPIN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3559007-B1 SULFONAMIDE COMPOUNDS HAVING TNAP INHIBITORY ACTIVITY DAIICHI SANKYO CO LTD (JP) 2023-08-16 EP disclosed
CN-110167946-B Sulfonamide compounds having TNAP inhibitory activity 第一三共株式会社 2022-04-08 CN disclosed
US-11046710-B2 Sulfonamide compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-06-29 US disclosed
US-11014939-B2 2021-05-25 US disclosed
US-20200087321-A1 SULFONAMIDE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087321-A1 SULFONAMIDE COMPOUNDS ALPI, ASAH2, STS TP53 3991/4885PPID 1168/4885MAPT 4589/4885
US-11014939-B2 ALPI, ALPP, ACER2 TP53 4387/4885PPID 2144/4885MAPT 4182/4885
US-11046710-B2 Sulfonamide compounds ALPI, ASAH2, STS TP53 3991/4885PPID 1168/4885MAPT 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.